Full Name
Yoshiaki Ito
Variants
Mahizhnan, A.
Ito, Y.
 
Main Affiliation
 
 
Email
csiitoy@nus.edu.sg
 
Other emails
 

Publications

Refined By:
Date Issued:  [2000 TO 2021]
Department:  PATHOLOGY

Results 1-20 of 20 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
12007CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancerLiu, Q. ; Ito, K. ; Shah, N. ; Ito, Y. ; Teh, M. ; Yeoh, K.G. 
22010Claudin-1 Has Tumor Suppressive Activity and Is a Direct Target of RUNX3 in Gastric Epithelial CellsChang, T.L. ; Ko, T.K. ; Liu, Q.; Salto-Tellez, M. ; Ito, Y. ; Ito, K. ; Yeoh, K.G. ; Fukamachi, H.
32010MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancerLai, K.W. ; Koh, K.X.; Loh, M. ; Tada, K. ; Subramaniam, M.M. ; Lim, X.Y. ; Vaithilingam, A. ; Salto-Tellez, M. ; Ito, Y. ; Soong, R. ; Iacopetta, B.
42010MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancerLai, K.W. ; Koh, K.X.; Loh, M. ; Tada, K. ; Subramaniam, M.M. ; Lim, X.Y. ; Vaithilingam, A. ; Salto-Tellez, M. ; Ito, Y. ; Soong, R. ; Iacopetta, B. 
52008RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal TumorigenesisIto, K. ; Lim, A.C.-B.; Motoda, L.; Osato, M. ; Chuang, L.S.H.; Lee, C.W.L.; Voon, D.C.-C.; Ito, Y. ; Salto-Tellez, M. ; Koo, J.K.W.; Wang, H.; Fukamachi, H.
62008RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal TumorigenesisIto, K. ; Lim, A.C.-B.; Motoda, L.; Osato, M. ; Chuang, L.S.H.; Lee, C.W.L.; Voon, D.C.-C.; Salto-Tellez, M. ; Koo, J.K.W.; Wang, H.; Ito, Y. ; Fukamachi, H.
72008RUNX3 Attenuates β-Catenin/T Cell Factors in Intestinal TumorigenesisIto, K. ; Lim, A.C.-B.; Motoda, L.; Osato, M. ; Chuang, L.S.H.; Lee, C.W.L.; Voon, D.C.-C.; Ito, Y. ; Salto-Tellez, M. ; Koo, J.K.W.; Wang, H.; Fukamachi, H.
82009RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progressionSubramaniam, M.M.; Chan, J.Y.; Soong, R. ; Ito, K. ; Ito, Y. ; Salto-Tellez, M. ; Putti, T.C. ; Yeoh, K.G. 
92009RUNX3 inactivation by frequent promoter hypermethylation and protein mislocalization constitute an early event in breast cancer progressionSubramaniam, M.M. ; Chan, J.Y.; Soong, R. ; Ito, K. ; Ito, Y. ; Salto-Tellez, M. ; Putti, T.C. ; Yeoh, K.G. 
102009RUNX3 inactivation in colorectal polyps arising through different pathways of colonic carcinogenesisSubramaniam, M.M. ; Chan, J.Y.; Soong, R. ; Ito, K. ; Ito, Y. ; Salto-Tellez, M. ; Chen, C.L.; Kumarasinghe, M.P. ; Yeoh, K.G. ; Wong, R.; Guenther, T.; Will, O.
112006RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancerLau, Q.C. ; Raja, E.; Salto-Tellez, M. ; Liu, Q. ; Ito, K. ; Inoue, M. ; Ko, T.K. ; Huang, C. ; Ito, Y. ; Sukumar, S. ; Putti, T.C. ; Loh, M.; Inoue, M.; Ito, Y. ; Bhalla, K.N.; Zhu, T.
121-Oct-2017RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYCSelvarajan, V ; Osato, M ; Nah, GSS ; Yan, J ; Chung, T-H ; Voon, DC-C ; Ito, Y ; Ham, MF; Salto-Tellez, M ; Shimizu, N; Choo, S-N; Fan, S; Chng, W-J ; Ng, S-B 
132006RUNX3 protein is overexpressed in human basal cell carcinomasSalto-Tellez, M. ; Chong, P.Y. ; Soong, R. ; Peh, B.K. ; Ito, K. ; Han, H.C.; Tada, K. ; Ito, Y. ; Tan, S.H.; Ong, W.Y.; Voon, D.C.
142006RUNX3 protein is overexpressed in human basal cell carcinomasSalto-Tellez, M. ; Chong, P.Y. ; Soong, R.; Peh, B.K. ; Ito, K. ; Chong, P.Y. ; Han, H.C.; Tada, K. ; Ito, Y. ; Tan, S.H.; Ong, W.Y.; Ito, K. ; Voon, D.C.
152006RUNX3 protein is overexpressed in human basal cell carcinomasSalto-Tellez, M. ; Chong, P.Y. ; Soong, R. ; Peh, B.K. ; Ito, K. ; Han, H.C.; Tada, K. ; Ito, Y. ; Tan, S.H.; Ong, W.Y.; Voon, D.C.
162005RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalizationIto, K. ; Yano, T.; Ida, H.; Inoue, M. ; Ito, Y. ; Liu, Q. ; Salto-Tellez, M. ; Tada, K. ; Huang, C. ; Shah, N. ; Hiong, K.C.; Peh, B.K. ; Han, H.C.; Ito, T.; Teh, M. ; Rajnakova, A.; Yeoh, K.G. 
172007Targets of genome copy number reduction in primary breast cancers identified by integrative genomicsChen, W.; Tan, L.K.; Tan, P.; Salto-Tellez, M. ; Ito, Y. ; Palanisamy, N.; Ganesan, K.; Hou, Q.; Wu, J.; Sii, L.H.; Tan, B.; Tay, A.; Tan, K.C.; Ang, E.; Tan, B.K.; Tan, P.H.; Ito, K.
182007Targets of genome copy number reduction in primary breast cancers identified by integrative genomicsChen, W.; Tan, L.K.; Tan, P. ; Salto-Tellez, M. ; Ito, Y. ; Palanisamy, N.; Ganesan, K.; Hou, Q.; Wu, J.; Sii, L.H.; Tan, B.; Tay, A.; Tan, K.C.; Ang, E.; Tan, B.K.; Tan, P.H. ; Ito, K. 
192009The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcomeSoong, R. ; Shah, N.; Peh, B.K. ; Chong, P.Y. ; Ng, S.S.; Salto-Tellez, M. ; Ito, Y. ; Zeps, N.; Joseph, D.; Iacopetta, B.
202009The expression of RUNX3 in colorectal cancer is associated with disease stage and patient outcomeSoong, R. ; Shah, N. ; Peh, B.K. ; Chong, P.Y. ; Ng, S.S.; Salto-Tellez, M. ; Ito, Y. ; Zeps, N.; Joseph, D.; Iacopetta, B.